nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—CYP2D6—Lomustine—brain cancer	0.111	0.496	CbGbCtD
Captopril—CYP2D6—Hydroxyurea—brain cancer	0.0844	0.376	CbGbCtD
Captopril—REN—vein—brain cancer	0.0293	0.105	CbGeAlD
Captopril—ABCB1—Etoposide—brain cancer	0.0286	0.127	CbGbCtD
Captopril—F2—vein—brain cancer	0.0204	0.0729	CbGeAlD
Captopril—ACE—vein—brain cancer	0.0125	0.0445	CbGeAlD
Captopril—Nephritis—Procarbazine—brain cancer	0.00996	0.0348	CcSEcCtD
Captopril—REN—blood vessel—brain cancer	0.00929	0.0332	CbGeAlD
Captopril—MMP2—endothelium—brain cancer	0.00926	0.0331	CbGeAlD
Captopril—REN—hindbrain—brain cancer	0.00886	0.0316	CbGeAlD
Captopril—MMP2—blood vessel—brain cancer	0.00854	0.0305	CbGeAlD
Captopril—MMP9—endothelium—brain cancer	0.00805	0.0288	CbGeAlD
Captopril—MMP9—blood vessel—brain cancer	0.00743	0.0265	CbGeAlD
Captopril—F2—endothelium—brain cancer	0.00703	0.0251	CbGeAlD
Captopril—Gastric irritation—Hydroxyurea—brain cancer	0.00679	0.0237	CcSEcCtD
Captopril—F2—blood vessel—brain cancer	0.00648	0.0231	CbGeAlD
Captopril—LTA4H—telencephalon—brain cancer	0.00584	0.0208	CbGeAlD
Captopril—Traumatic liver injury—Temozolomide—brain cancer	0.00552	0.0193	CcSEcCtD
Captopril—REN—brainstem—brain cancer	0.00508	0.0181	CbGeAlD
Captopril—Epigastric discomfort—Hydroxyurea—brain cancer	0.00501	0.0175	CcSEcCtD
Captopril—ACE—ganglion—brain cancer	0.00498	0.0178	CbGeAlD
Captopril—LTA4H—gonad—brain cancer	0.00487	0.0174	CbGeAlD
Captopril—LTA4H—pituitary gland—brain cancer	0.00475	0.017	CbGeAlD
Captopril—LTA4H—medulla oblongata—brain cancer	0.00459	0.0164	CbGeAlD
Captopril—ACE—endothelium—brain cancer	0.00429	0.0153	CbGeAlD
Captopril—LTA4H—midbrain—brain cancer	0.00419	0.015	CbGeAlD
Captopril—LTA4H—spinal cord—brain cancer	0.00409	0.0146	CbGeAlD
Captopril—ACE—blood vessel—brain cancer	0.00396	0.0141	CbGeAlD
Captopril—LTA4H—endocrine gland—brain cancer	0.00368	0.0131	CbGeAlD
Captopril—REN—pituitary gland—brain cancer	0.00367	0.0131	CbGeAlD
Captopril—Ataxia—Lomustine—brain cancer	0.00366	0.0128	CcSEcCtD
Captopril—Blister—Hydroxyurea—brain cancer	0.00365	0.0128	CcSEcCtD
Captopril—LTA4H—head—brain cancer	0.00364	0.013	CbGeAlD
Captopril—MMP2—gonad—brain cancer	0.00346	0.0123	CbGeAlD
Captopril—Myasthenia—Carmustine—brain cancer	0.00339	0.0118	CcSEcCtD
Captopril—MMP2—pituitary gland—brain cancer	0.00337	0.012	CbGeAlD
Captopril—LTA4H—central nervous system—brain cancer	0.00332	0.0118	CbGeAlD
Captopril—MMP2—medulla oblongata—brain cancer	0.00326	0.0116	CbGeAlD
Captopril—LTA4H—cerebellum—brain cancer	0.00324	0.0116	CbGeAlD
Captopril—Pancytopenia—Lomustine—brain cancer	0.00319	0.0112	CcSEcCtD
Captopril—Gynaecomastia—Procarbazine—brain cancer	0.00304	0.0106	CcSEcCtD
Captopril—MMP2—midbrain—brain cancer	0.00298	0.0106	CbGeAlD
Captopril—Renal failure—Lomustine—brain cancer	0.00295	0.0103	CcSEcCtD
Captopril—Stomatitis—Lomustine—brain cancer	0.00292	0.0102	CcSEcCtD
Captopril—MMP2—spinal cord—brain cancer	0.0029	0.0104	CbGeAlD
Captopril—REN—endocrine gland—brain cancer	0.00284	0.0101	CbGeAlD
Captopril—Photosensitivity—Procarbazine—brain cancer	0.00281	0.00983	CcSEcCtD
Captopril—REN—head—brain cancer	0.00281	0.01	CbGeAlD
Captopril—Ulcer—Hydroxyurea—brain cancer	0.00278	0.00973	CcSEcCtD
Captopril—Haemolytic anaemia—Procarbazine—brain cancer	0.00274	0.00956	CcSEcCtD
Captopril—Necrosis—Carmustine—brain cancer	0.00271	0.00948	CcSEcCtD
Captopril—Cholestasis—Temozolomide—brain cancer	0.00271	0.00947	CcSEcCtD
Captopril—LTA4H—brain—brain cancer	0.00263	0.00941	CbGeAlD
Captopril—MMP2—endocrine gland—brain cancer	0.00261	0.00933	CbGeAlD
Captopril—MMP2—head—brain cancer	0.00258	0.00921	CbGeAlD
Captopril—REN—central nervous system—brain cancer	0.00256	0.00915	CbGeAlD
Captopril—MMP9—spinal cord—brain cancer	0.00252	0.00901	CbGeAlD
Captopril—REN—cerebellum—brain cancer	0.0025	0.00894	CbGeAlD
Captopril—Liver injury—Temozolomide—brain cancer	0.00244	0.00854	CcSEcCtD
Captopril—Alopecia—Lomustine—brain cancer	0.00238	0.00831	CcSEcCtD
Captopril—MMP2—central nervous system—brain cancer	0.00235	0.00841	CbGeAlD
Captopril—Ataxia—Procarbazine—brain cancer	0.00232	0.00812	CcSEcCtD
Captopril—Drug interaction—Carmustine—brain cancer	0.00229	0.00802	CcSEcCtD
Captopril—MMP9—endocrine gland—brain cancer	0.00227	0.00811	CbGeAlD
Captopril—MMP9—head—brain cancer	0.00224	0.00801	CbGeAlD
Captopril—F2—spinal cord—brain cancer	0.0022	0.00786	CbGeAlD
Captopril—Eosinophilia—Procarbazine—brain cancer	0.00211	0.00739	CcSEcCtD
Captopril—Necrosis—Etoposide—brain cancer	0.0021	0.00733	CcSEcCtD
Captopril—Pancreatitis—Procarbazine—brain cancer	0.00209	0.00732	CcSEcCtD
Captopril—Angina pectoris—Procarbazine—brain cancer	0.00208	0.00727	CcSEcCtD
Captopril—Renal failure acute—Hydroxyurea—brain cancer	0.00207	0.00724	CcSEcCtD
Captopril—MMP9—central nervous system—brain cancer	0.00205	0.00731	CbGeAlD
Captopril—REN—brain—brain cancer	0.00203	0.00726	CbGeAlD
Captopril—Pancytopenia—Procarbazine—brain cancer	0.00203	0.00709	CcSEcCtD
Captopril—Dermatitis bullous—Hydroxyurea—brain cancer	0.002	0.00699	CcSEcCtD
Captopril—F2—endocrine gland—brain cancer	0.00198	0.00708	CbGeAlD
Captopril—Pollakiuria—Procarbazine—brain cancer	0.00197	0.00689	CcSEcCtD
Captopril—F2—head—brain cancer	0.00196	0.00699	CbGeAlD
Captopril—Photosensitivity reaction—Procarbazine—brain cancer	0.00195	0.00681	CcSEcCtD
Captopril—ACE—telencephalon—brain cancer	0.00192	0.00686	CbGeAlD
Captopril—Gynaecomastia—Carmustine—brain cancer	0.0019	0.00666	CcSEcCtD
Captopril—Dry eye—Temozolomide—brain cancer	0.0019	0.00664	CcSEcCtD
Captopril—Thrombocytopenia—Lomustine—brain cancer	0.00187	0.00654	CcSEcCtD
Captopril—MMP2—brain—brain cancer	0.00187	0.00667	CbGeAlD
Captopril—Stomatitis—Procarbazine—brain cancer	0.00185	0.00648	CcSEcCtD
Captopril—Jaundice—Procarbazine—brain cancer	0.00185	0.00648	CcSEcCtD
Captopril—CYP2D6—hindbrain—brain cancer	0.00185	0.0066	CbGeAlD
Captopril—Anorexia—Lomustine—brain cancer	0.00182	0.00637	CcSEcCtD
Captopril—F2—central nervous system—brain cancer	0.00179	0.00638	CbGeAlD
Captopril—Diabetes mellitus—Carmustine—brain cancer	0.00178	0.00621	CcSEcCtD
Captopril—Ulcer—Etoposide—brain cancer	0.00174	0.00608	CcSEcCtD
Captopril—Body temperature increased—Carboplatin—brain cancer	0.00173	0.00604	CcSEcCtD
Captopril—Hallucination—Procarbazine—brain cancer	0.0017	0.00594	CcSEcCtD
Captopril—SLC15A1—endocrine gland—brain cancer	0.00169	0.00603	CbGeAlD
Captopril—Decreased appetite—Lomustine—brain cancer	0.00166	0.00581	CcSEcCtD
Captopril—MMP9—brain—brain cancer	0.00163	0.0058	CbGeAlD
Captopril—Pancreatitis—Hydroxyurea—brain cancer	0.00162	0.00566	CcSEcCtD
Captopril—ACE—gonad—brain cancer	0.0016	0.00572	CbGeAlD
Captopril—Flushing—Procarbazine—brain cancer	0.00159	0.00554	CcSEcCtD
Captopril—Dermatitis exfoliative—Temozolomide—brain cancer	0.00158	0.00553	CcSEcCtD
Captopril—Pancytopenia—Hydroxyurea—brain cancer	0.00157	0.00548	CcSEcCtD
Captopril—ACE—pituitary gland—brain cancer	0.00156	0.00558	CbGeAlD
Captopril—Hyponatraemia—Carmustine—brain cancer	0.00155	0.00542	CcSEcCtD
Captopril—Neutropenia—Hydroxyurea—brain cancer	0.00154	0.0054	CcSEcCtD
Captopril—Body temperature increased—Lomustine—brain cancer	0.00151	0.00528	CcSEcCtD
Captopril—Alopecia—Procarbazine—brain cancer	0.00151	0.00528	CcSEcCtD
Captopril—Tension—Procarbazine—brain cancer	0.00146	0.0051	CcSEcCtD
Captopril—Ataxia—Carmustine—brain cancer	0.00145	0.00508	CcSEcCtD
Captopril—SLC22A6—brain—brain cancer	0.00145	0.00519	CbGeAlD
Captopril—Nervousness—Procarbazine—brain cancer	0.00144	0.00505	CcSEcCtD
Captopril—Stomatitis—Hydroxyurea—brain cancer	0.00144	0.00502	CcSEcCtD
Captopril—F2—brain—brain cancer	0.00142	0.00506	CbGeAlD
Captopril—Ataxia—Temozolomide—brain cancer	0.0014	0.00491	CcSEcCtD
Captopril—ABCB1—blood vessel—brain cancer	0.00139	0.00498	CbGeAlD
Captopril—Anaemia—Procarbazine—brain cancer	0.00137	0.00481	CcSEcCtD
Captopril—Muscular weakness—Carmustine—brain cancer	0.00136	0.00476	CcSEcCtD
Captopril—ACE—spinal cord—brain cancer	0.00135	0.0048	CbGeAlD
Captopril—Syncope—Procarbazine—brain cancer	0.00133	0.00466	CcSEcCtD
Captopril—Muscular weakness—Temozolomide—brain cancer	0.00132	0.0046	CcSEcCtD
Captopril—Hallucination—Hydroxyurea—brain cancer	0.00132	0.0046	CcSEcCtD
Captopril—Loss of consciousness—Procarbazine—brain cancer	0.00131	0.00457	CcSEcCtD
Captopril—Cough—Procarbazine—brain cancer	0.0013	0.00454	CcSEcCtD
Captopril—Pancytopenia—Carmustine—brain cancer	0.00127	0.00443	CcSEcCtD
Captopril—Arthralgia—Procarbazine—brain cancer	0.00127	0.00443	CcSEcCtD
Captopril—Myalgia—Procarbazine—brain cancer	0.00127	0.00443	CcSEcCtD
Captopril—Neutropenia—Carmustine—brain cancer	0.00125	0.00436	CcSEcCtD
Captopril—Dry mouth—Procarbazine—brain cancer	0.00124	0.00433	CcSEcCtD
Captopril—Anaphylactoid reaction—Etoposide—brain cancer	0.00123	0.00432	CcSEcCtD
Captopril—Pancytopenia—Temozolomide—brain cancer	0.00123	0.00428	CcSEcCtD
Captopril—Confusional state—Procarbazine—brain cancer	0.00122	0.00428	CcSEcCtD
Captopril—Vomiting—Lomustine—brain cancer	0.00122	0.00425	CcSEcCtD
Captopril—ACE—endocrine gland—brain cancer	0.00121	0.00432	CbGeAlD
Captopril—Neutropenia—Temozolomide—brain cancer	0.00121	0.00422	CcSEcCtD
Captopril—ACE—head—brain cancer	0.0012	0.00427	CbGeAlD
Captopril—Shock—Procarbazine—brain cancer	0.00119	0.00417	CcSEcCtD
Captopril—Pollakiuria—Temozolomide—brain cancer	0.00119	0.00417	CcSEcCtD
Captopril—Erectile dysfunction—Temozolomide—brain cancer	0.00119	0.00415	CcSEcCtD
Captopril—Thrombocytopenia—Procarbazine—brain cancer	0.00119	0.00415	CcSEcCtD
Captopril—Tachycardia—Procarbazine—brain cancer	0.00118	0.00414	CcSEcCtD
Captopril—Photosensitivity reaction—Temozolomide—brain cancer	0.00118	0.00412	CcSEcCtD
Captopril—Renal failure—Carmustine—brain cancer	0.00117	0.00409	CcSEcCtD
Captopril—Alopecia—Hydroxyurea—brain cancer	0.00117	0.00408	CcSEcCtD
Captopril—Weight decreased—Temozolomide—brain cancer	0.00117	0.00408	CcSEcCtD
Captopril—Stomatitis—Carmustine—brain cancer	0.00116	0.00406	CcSEcCtD
Captopril—Anorexia—Procarbazine—brain cancer	0.00116	0.00404	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00114	0.00399	CcSEcCtD
Captopril—Cardiac arrest—Etoposide—brain cancer	0.00114	0.00397	CcSEcCtD
Captopril—Nausea—Lomustine—brain cancer	0.00114	0.00397	CcSEcCtD
Captopril—Hypotension—Procarbazine—brain cancer	0.00113	0.00396	CcSEcCtD
Captopril—Stomatitis—Temozolomide—brain cancer	0.00112	0.00392	CcSEcCtD
Captopril—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00111	0.00387	CcSEcCtD
Captopril—Insomnia—Procarbazine—brain cancer	0.0011	0.00384	CcSEcCtD
Captopril—ACE—central nervous system—brain cancer	0.00109	0.0039	CbGeAlD
Captopril—Paraesthesia—Procarbazine—brain cancer	0.00109	0.00381	CcSEcCtD
Captopril—Somnolence—Procarbazine—brain cancer	0.00108	0.00377	CcSEcCtD
Captopril—Ill-defined disorder—Hydroxyurea—brain cancer	0.00107	0.00373	CcSEcCtD
Captopril—Anaemia—Hydroxyurea—brain cancer	0.00106	0.00372	CcSEcCtD
Captopril—Hallucination—Carmustine—brain cancer	0.00106	0.00372	CcSEcCtD
Captopril—CYP2D6—brainstem—brain cancer	0.00106	0.00378	CbGeAlD
Captopril—Decreased appetite—Procarbazine—brain cancer	0.00106	0.00369	CcSEcCtD
Captopril—Fatigue—Procarbazine—brain cancer	0.00105	0.00366	CcSEcCtD
Captopril—Malaise—Hydroxyurea—brain cancer	0.00104	0.00363	CcSEcCtD
Captopril—Constipation—Procarbazine—brain cancer	0.00104	0.00363	CcSEcCtD
Captopril—Hepatitis—Temozolomide—brain cancer	0.00103	0.00361	CcSEcCtD
Captopril—Hallucination—Temozolomide—brain cancer	0.00103	0.00359	CcSEcCtD
Captopril—Pharyngitis—Temozolomide—brain cancer	0.00103	0.00358	CcSEcCtD
Captopril—Bronchospasm—Etoposide—brain cancer	0.00102	0.00355	CcSEcCtD
Captopril—Feeling abnormal—Procarbazine—brain cancer	0.001	0.0035	CcSEcCtD
Captopril—Gastrointestinal pain—Procarbazine—brain cancer	0.000992	0.00347	CcSEcCtD
Captopril—Flushing—Carmustine—brain cancer	0.000992	0.00347	CcSEcCtD
Captopril—Pancytopenia—Etoposide—brain cancer	0.000981	0.00343	CcSEcCtD
Captopril—Erythema multiforme—Temozolomide—brain cancer	0.000977	0.00341	CcSEcCtD
Captopril—Discomfort—Hydroxyurea—brain cancer	0.000968	0.00338	CcSEcCtD
Captopril—Neutropenia—Etoposide—brain cancer	0.000966	0.00338	CcSEcCtD
Captopril—Body temperature increased—Procarbazine—brain cancer	0.000959	0.00335	CcSEcCtD
Captopril—Abdominal pain—Procarbazine—brain cancer	0.000959	0.00335	CcSEcCtD
Captopril—Flushing—Temozolomide—brain cancer	0.000959	0.00335	CcSEcCtD
Captopril—Alopecia—Carmustine—brain cancer	0.000944	0.0033	CcSEcCtD
Captopril—CYP2D6—telencephalon—brain cancer	0.00094	0.00336	CbGeAlD
Captopril—Thrombocytopenia—Hydroxyurea—brain cancer	0.00092	0.00322	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000913	0.00319	CcSEcCtD
Captopril—Alopecia—Temozolomide—brain cancer	0.000913	0.00319	CcSEcCtD
Captopril—ALB—brain—brain cancer	0.000905	0.00323	CbGeAlD
Captopril—Renal failure—Etoposide—brain cancer	0.000905	0.00316	CcSEcCtD
Captopril—Stomatitis—Etoposide—brain cancer	0.000897	0.00314	CcSEcCtD
Captopril—Jaundice—Etoposide—brain cancer	0.000897	0.00314	CcSEcCtD
Captopril—Anorexia—Hydroxyurea—brain cancer	0.000895	0.00313	CcSEcCtD
Captopril—Dysgeusia—Temozolomide—brain cancer	0.00088	0.00308	CcSEcCtD
Captopril—Vision blurred—Carmustine—brain cancer	0.000877	0.00307	CcSEcCtD
Captopril—Asthenia—Procarbazine—brain cancer	0.000871	0.00304	CcSEcCtD
Captopril—ACE—brain—brain cancer	0.000867	0.00309	CbGeAlD
Captopril—Anaemia—Carmustine—brain cancer	0.00086	0.00301	CcSEcCtD
Captopril—Agranulocytosis—Etoposide—brain cancer	0.000859	0.003	CcSEcCtD
Captopril—Pruritus—Procarbazine—brain cancer	0.000859	0.003	CcSEcCtD
Captopril—Vision blurred—Temozolomide—brain cancer	0.000847	0.00296	CcSEcCtD
Captopril—Dyspnoea—Hydroxyurea—brain cancer	0.000837	0.00293	CcSEcCtD
Captopril—Somnolence—Hydroxyurea—brain cancer	0.000835	0.00292	CcSEcCtD
Captopril—Ill-defined disorder—Temozolomide—brain cancer	0.000834	0.00292	CcSEcCtD
Captopril—Anaemia—Temozolomide—brain cancer	0.000831	0.00291	CcSEcCtD
Captopril—Diarrhoea—Procarbazine—brain cancer	0.00083	0.0029	CcSEcCtD
Captopril—Dyspepsia—Hydroxyurea—brain cancer	0.000827	0.00289	CcSEcCtD
Captopril—Angioedema—Temozolomide—brain cancer	0.000822	0.00287	CcSEcCtD
Captopril—Decreased appetite—Hydroxyurea—brain cancer	0.000817	0.00285	CcSEcCtD
Captopril—Malaise—Temozolomide—brain cancer	0.000811	0.00283	CcSEcCtD
Captopril—Fatigue—Hydroxyurea—brain cancer	0.00081	0.00283	CcSEcCtD
Captopril—Constipation—Hydroxyurea—brain cancer	0.000803	0.00281	CcSEcCtD
Captopril—Dizziness—Procarbazine—brain cancer	0.000803	0.00281	CcSEcCtD
Captopril—Palpitations—Temozolomide—brain cancer	0.000795	0.00278	CcSEcCtD
Captopril—Myalgia—Carmustine—brain cancer	0.000792	0.00277	CcSEcCtD
Captopril—Chest pain—Carmustine—brain cancer	0.000792	0.00277	CcSEcCtD
Captopril—Cough—Temozolomide—brain cancer	0.000785	0.00274	CcSEcCtD
Captopril—Erythema multiforme—Etoposide—brain cancer	0.000781	0.00273	CcSEcCtD
Captopril—Feeling abnormal—Hydroxyurea—brain cancer	0.000774	0.00271	CcSEcCtD
Captopril—Vomiting—Procarbazine—brain cancer	0.000772	0.0027	CcSEcCtD
Captopril—Flushing—Etoposide—brain cancer	0.000767	0.00268	CcSEcCtD
Captopril—Confusional state—Carmustine—brain cancer	0.000766	0.00268	CcSEcCtD
Captopril—Myalgia—Temozolomide—brain cancer	0.000765	0.00268	CcSEcCtD
Captopril—Arthralgia—Temozolomide—brain cancer	0.000765	0.00268	CcSEcCtD
Captopril—Rash—Procarbazine—brain cancer	0.000765	0.00268	CcSEcCtD
Captopril—Dermatitis—Procarbazine—brain cancer	0.000765	0.00267	CcSEcCtD
Captopril—Headache—Procarbazine—brain cancer	0.00076	0.00266	CcSEcCtD
Captopril—Discomfort—Temozolomide—brain cancer	0.000756	0.00264	CcSEcCtD
Captopril—Dry mouth—Temozolomide—brain cancer	0.000749	0.00262	CcSEcCtD
Captopril—Thrombocytopenia—Carmustine—brain cancer	0.000743	0.0026	CcSEcCtD
Captopril—Body temperature increased—Hydroxyurea—brain cancer	0.000743	0.0026	CcSEcCtD
Captopril—Tachycardia—Carmustine—brain cancer	0.000741	0.00259	CcSEcCtD
Captopril—Confusional state—Temozolomide—brain cancer	0.00074	0.00259	CcSEcCtD
Captopril—Anaphylactic shock—Temozolomide—brain cancer	0.000734	0.00257	CcSEcCtD
Captopril—Alopecia—Etoposide—brain cancer	0.00073	0.00255	CcSEcCtD
Captopril—Anorexia—Carmustine—brain cancer	0.000724	0.00253	CcSEcCtD
Captopril—Nausea—Procarbazine—brain cancer	0.000721	0.00252	CcSEcCtD
Captopril—Thrombocytopenia—Temozolomide—brain cancer	0.000718	0.00251	CcSEcCtD
Captopril—Hypotension—Carmustine—brain cancer	0.00071	0.00248	CcSEcCtD
Captopril—Dysgeusia—Etoposide—brain cancer	0.000705	0.00246	CcSEcCtD
Captopril—Anorexia—Temozolomide—brain cancer	0.000699	0.00245	CcSEcCtD
Captopril—Musculoskeletal discomfort—Carmustine—brain cancer	0.000692	0.00242	CcSEcCtD
Captopril—Insomnia—Carmustine—brain cancer	0.000687	0.0024	CcSEcCtD
Captopril—Paraesthesia—Carmustine—brain cancer	0.000682	0.00238	CcSEcCtD
Captopril—Dyspnoea—Carmustine—brain cancer	0.000677	0.00237	CcSEcCtD
Captopril—ABCB1—telencephalon—brain cancer	0.000676	0.00241	CbGeAlD
Captopril—Somnolence—Carmustine—brain cancer	0.000675	0.00236	CcSEcCtD
Captopril—Asthenia—Hydroxyurea—brain cancer	0.000674	0.00236	CcSEcCtD
Captopril—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000669	0.00234	CcSEcCtD
Captopril—Ill-defined disorder—Etoposide—brain cancer	0.000668	0.00233	CcSEcCtD
Captopril—Anaemia—Etoposide—brain cancer	0.000665	0.00232	CcSEcCtD
Captopril—Insomnia—Temozolomide—brain cancer	0.000664	0.00232	CcSEcCtD
Captopril—Decreased appetite—Carmustine—brain cancer	0.00066	0.00231	CcSEcCtD
Captopril—Paraesthesia—Temozolomide—brain cancer	0.000659	0.0023	CcSEcCtD
Captopril—Dyspnoea—Temozolomide—brain cancer	0.000654	0.00229	CcSEcCtD
Captopril—Somnolence—Temozolomide—brain cancer	0.000652	0.00228	CcSEcCtD
Captopril—Constipation—Carmustine—brain cancer	0.000649	0.00227	CcSEcCtD
Captopril—Malaise—Etoposide—brain cancer	0.000649	0.00227	CcSEcCtD
Captopril—Dyspepsia—Temozolomide—brain cancer	0.000646	0.00226	CcSEcCtD
Captopril—Diarrhoea—Hydroxyurea—brain cancer	0.000643	0.00225	CcSEcCtD
Captopril—Decreased appetite—Temozolomide—brain cancer	0.000638	0.00223	CcSEcCtD
Captopril—Fatigue—Temozolomide—brain cancer	0.000633	0.00221	CcSEcCtD
Captopril—Loss of consciousness—Etoposide—brain cancer	0.000632	0.00221	CcSEcCtD
Captopril—Cough—Etoposide—brain cancer	0.000628	0.00219	CcSEcCtD
Captopril—Constipation—Temozolomide—brain cancer	0.000627	0.00219	CcSEcCtD
Captopril—Feeling abnormal—Carmustine—brain cancer	0.000626	0.00219	CcSEcCtD
Captopril—Dizziness—Hydroxyurea—brain cancer	0.000621	0.00217	CcSEcCtD
Captopril—Gastrointestinal pain—Carmustine—brain cancer	0.000621	0.00217	CcSEcCtD
Captopril—Chest pain—Etoposide—brain cancer	0.000613	0.00214	CcSEcCtD
Captopril—Discomfort—Etoposide—brain cancer	0.000605	0.00212	CcSEcCtD
Captopril—Feeling abnormal—Temozolomide—brain cancer	0.000605	0.00211	CcSEcCtD
Captopril—Body temperature increased—Carmustine—brain cancer	0.0006	0.0021	CcSEcCtD
Captopril—Abdominal pain—Carmustine—brain cancer	0.0006	0.0021	CcSEcCtD
Captopril—Gastrointestinal pain—Temozolomide—brain cancer	0.0006	0.0021	CcSEcCtD
Captopril—Vomiting—Hydroxyurea—brain cancer	0.000597	0.00209	CcSEcCtD
Captopril—CYP2D6—endocrine gland—brain cancer	0.000593	0.00212	CbGeAlD
Captopril—Rash—Hydroxyurea—brain cancer	0.000592	0.00207	CcSEcCtD
Captopril—Confusional state—Etoposide—brain cancer	0.000592	0.00207	CcSEcCtD
Captopril—Dermatitis—Hydroxyurea—brain cancer	0.000592	0.00207	CcSEcCtD
Captopril—Headache—Hydroxyurea—brain cancer	0.000588	0.00206	CcSEcCtD
Captopril—Anaphylactic shock—Etoposide—brain cancer	0.000587	0.00205	CcSEcCtD
Captopril—CYP2D6—head—brain cancer	0.000585	0.00209	CbGeAlD
Captopril—Body temperature increased—Temozolomide—brain cancer	0.00058	0.00203	CcSEcCtD
Captopril—Abdominal pain—Temozolomide—brain cancer	0.00058	0.00203	CcSEcCtD
Captopril—Thrombocytopenia—Etoposide—brain cancer	0.000575	0.00201	CcSEcCtD
Captopril—Tachycardia—Etoposide—brain cancer	0.000573	0.002	CcSEcCtD
Captopril—ABCB1—gonad—brain cancer	0.000564	0.00201	CbGeAlD
Captopril—Anorexia—Etoposide—brain cancer	0.00056	0.00196	CcSEcCtD
Captopril—Nausea—Hydroxyurea—brain cancer	0.000558	0.00195	CcSEcCtD
Captopril—ABCB1—pituitary gland—brain cancer	0.00055	0.00197	CbGeAlD
Captopril—Hypotension—Etoposide—brain cancer	0.000549	0.00192	CcSEcCtD
Captopril—Asthenia—Carmustine—brain cancer	0.000545	0.0019	CcSEcCtD
Captopril—CYP2D6—central nervous system—brain cancer	0.000534	0.00191	CbGeAlD
Captopril—ABCB1—medulla oblongata—brain cancer	0.000531	0.0019	CbGeAlD
Captopril—MMP9—AP-1 transcription factor network—CTNNB1—brain cancer	0.000529	0.00253	CbGpPWpGaD
Captopril—Paraesthesia—Etoposide—brain cancer	0.000527	0.00184	CcSEcCtD
Captopril—Asthenia—Temozolomide—brain cancer	0.000526	0.00184	CcSEcCtD
Captopril—LTA4H—Metabolism—ENO2—brain cancer	0.000524	0.0025	CbGpPWpGaD
Captopril—Dyspnoea—Etoposide—brain cancer	0.000523	0.00183	CcSEcCtD
Captopril—MMP2—Developmental Biology—TRPC6—brain cancer	0.000523	0.0025	CbGpPWpGaD
Captopril—CYP2D6—cerebellum—brain cancer	0.000522	0.00186	CbGeAlD
Captopril—Somnolence—Etoposide—brain cancer	0.000522	0.00182	CcSEcCtD
Captopril—Diarrhoea—Carmustine—brain cancer	0.00052	0.00182	CcSEcCtD
Captopril—Pruritus—Temozolomide—brain cancer	0.000519	0.00181	CcSEcCtD
Captopril—F2—Regulation of Actin Cytoskeleton—VAV1—brain cancer	0.000518	0.00247	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000515	0.00246	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—SPP1—brain cancer	0.000514	0.00245	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—OR4C12—brain cancer	0.000513	0.00245	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—OR14C36—brain cancer	0.000513	0.00245	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000512	0.00244	CbGpPWpGaD
Captopril—Decreased appetite—Etoposide—brain cancer	0.00051	0.00178	CcSEcCtD
Captopril—Fatigue—Etoposide—brain cancer	0.000506	0.00177	CcSEcCtD
Captopril—F2—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000504	0.00241	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—IRS2—brain cancer	0.000504	0.0024	CbGpPWpGaD
Captopril—Dizziness—Carmustine—brain cancer	0.000502	0.00176	CcSEcCtD
Captopril—Constipation—Etoposide—brain cancer	0.000502	0.00176	CcSEcCtD
Captopril—Diarrhoea—Temozolomide—brain cancer	0.000502	0.00176	CcSEcCtD
Captopril—SLC15A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000501	0.00239	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—VEGFA—brain cancer	0.000501	0.00239	CbGpPWpGaD
Captopril—F2—Folate Metabolism—RELA—brain cancer	0.000493	0.00235	CbGpPWpGaD
Captopril—ABCB1—midbrain—brain cancer	0.000486	0.00173	CbGeAlD
Captopril—Dizziness—Temozolomide—brain cancer	0.000485	0.0017	CcSEcCtD
Captopril—Feeling abnormal—Etoposide—brain cancer	0.000484	0.00169	CcSEcCtD
Captopril—MMP9—AGE/RAGE pathway—STAT3—brain cancer	0.000484	0.00231	CbGpPWpGaD
Captopril—Vomiting—Carmustine—brain cancer	0.000483	0.00169	CcSEcCtD
Captopril—MMP9—Axon guidance—TRPC6—brain cancer	0.000481	0.00229	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.00048	0.00229	CbGpPWpGaD
Captopril—Gastrointestinal pain—Etoposide—brain cancer	0.00048	0.00168	CcSEcCtD
Captopril—Rash—Carmustine—brain cancer	0.000479	0.00167	CcSEcCtD
Captopril—Dermatitis—Carmustine—brain cancer	0.000478	0.00167	CcSEcCtD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000476	0.00227	CbGpPWpGaD
Captopril—Headache—Carmustine—brain cancer	0.000476	0.00166	CcSEcCtD
Captopril—ABCB1—spinal cord—brain cancer	0.000474	0.00169	CbGeAlD
Captopril—Vomiting—Temozolomide—brain cancer	0.000467	0.00163	CcSEcCtD
Captopril—F2—Signaling by GPCR—OR4C12—brain cancer	0.000466	0.00222	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—OR14C36—brain cancer	0.000466	0.00222	CbGpPWpGaD
Captopril—Abdominal pain—Etoposide—brain cancer	0.000464	0.00162	CcSEcCtD
Captopril—Body temperature increased—Etoposide—brain cancer	0.000464	0.00162	CcSEcCtD
Captopril—Rash—Temozolomide—brain cancer	0.000463	0.00162	CcSEcCtD
Captopril—Dermatitis—Temozolomide—brain cancer	0.000462	0.00162	CcSEcCtD
Captopril—Headache—Temozolomide—brain cancer	0.00046	0.00161	CcSEcCtD
Captopril—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000452	0.00216	CbGpPWpGaD
Captopril—Nausea—Carmustine—brain cancer	0.000451	0.00158	CcSEcCtD
Captopril—MMP9—LPA receptor mediated events—EGFR—brain cancer	0.000451	0.00215	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IL2—brain cancer	0.000444	0.00212	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—EGFR—brain cancer	0.00044	0.0021	CbGpPWpGaD
Captopril—Nausea—Temozolomide—brain cancer	0.000436	0.00152	CcSEcCtD
Captopril—MMP9—AP-1 transcription factor network—MYC—brain cancer	0.000429	0.00205	CbGpPWpGaD
Captopril—ABCB1—endocrine gland—brain cancer	0.000426	0.00152	CbGeAlD
Captopril—CYP2D6—brain—brain cancer	0.000424	0.00151	CbGeAlD
Captopril—F2—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	0.000424	0.00202	CbGpPWpGaD
Captopril—Asthenia—Etoposide—brain cancer	0.000421	0.00147	CcSEcCtD
Captopril—ABCB1—head—brain cancer	0.000421	0.0015	CbGeAlD
Captopril—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.000416	0.00198	CbGpPWpGaD
Captopril—Pruritus—Etoposide—brain cancer	0.000415	0.00145	CcSEcCtD
Captopril—Diarrhoea—Etoposide—brain cancer	0.000402	0.0014	CcSEcCtD
Captopril—MMP9—CXCR4-mediated signaling events—STAT3—brain cancer	0.000399	0.0019	CbGpPWpGaD
Captopril—F2—Hemostasis—BSG—brain cancer	0.000396	0.00189	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—RELA—brain cancer	0.000391	0.00187	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—MYC—brain cancer	0.000389	0.00186	CbGpPWpGaD
Captopril—Dizziness—Etoposide—brain cancer	0.000388	0.00136	CcSEcCtD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000385	0.00184	CbGpPWpGaD
Captopril—ABCB1—central nervous system—brain cancer	0.000384	0.00137	CbGeAlD
Captopril—F2—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000378	0.0018	CbGpPWpGaD
Captopril—ABCB1—cerebellum—brain cancer	0.000376	0.00134	CbGeAlD
Captopril—Vomiting—Etoposide—brain cancer	0.000373	0.00131	CcSEcCtD
Captopril—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000372	0.00177	CbGpPWpGaD
Captopril—Rash—Etoposide—brain cancer	0.00037	0.00129	CcSEcCtD
Captopril—Dermatitis—Etoposide—brain cancer	0.00037	0.00129	CcSEcCtD
Captopril—MMP9—EPH-Ephrin signaling—VEGFA—brain cancer	0.000368	0.00176	CbGpPWpGaD
Captopril—Headache—Etoposide—brain cancer	0.000368	0.00129	CcSEcCtD
Captopril—MMP2—Direct p53 effectors—EGFR—brain cancer	0.000367	0.00175	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000362	0.00173	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL2—brain cancer	0.000361	0.00172	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000359	0.00171	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000357	0.0017	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—OR4C12—brain cancer	0.000356	0.0017	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—OR14C36—brain cancer	0.000356	0.0017	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TP53—brain cancer	0.000352	0.00168	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CCND1—brain cancer	0.000352	0.00168	CbGpPWpGaD
Captopril—Nausea—Etoposide—brain cancer	0.000349	0.00122	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—ERBB2—brain cancer	0.000346	0.00165	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TRPC6—brain cancer	0.000343	0.00164	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—SOD2—brain cancer	0.000338	0.00161	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—SPP1—brain cancer	0.000337	0.00161	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—HES1—brain cancer	0.000337	0.00161	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	0.000329	0.00157	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—APC—brain cancer	0.000329	0.00157	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TP53—brain cancer	0.00032	0.00152	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—TP53—brain cancer	0.000308	0.00147	CbGpPWpGaD
Captopril—ABCB1—brain—brain cancer	0.000305	0.00109	CbGeAlD
Captopril—MMP9—Signaling Pathways—DTX2—brain cancer	0.000303	0.00145	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—SHH—brain cancer	0.000301	0.00144	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PTCH2—brain cancer	0.0003	0.00143	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—SMO—brain cancer	0.000286	0.00136	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—PTCH1—brain cancer	0.000286	0.00136	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TP53—brain cancer	0.000285	0.00136	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—MYC—brain cancer	0.000282	0.00135	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—EGFR—brain cancer	0.000276	0.00132	CbGpPWpGaD
Captopril—F2—Signaling Pathways—OR4C12—brain cancer	0.000275	0.00131	CbGpPWpGaD
Captopril—F2—Signaling Pathways—OR14C36—brain cancer	0.000275	0.00131	CbGpPWpGaD
Captopril—MMP2—Axon guidance—ERBB2—brain cancer	0.000271	0.00129	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.000269	0.00128	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CDK4—brain cancer	0.000264	0.00126	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—STAT3—brain cancer	0.000264	0.00126	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—CTNNB1—brain cancer	0.000263	0.00125	CbGpPWpGaD
Captopril—F2—Hemostasis—TRPC6—brain cancer	0.00026	0.00124	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—ABR—brain cancer	0.000259	0.00124	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000245	0.00117	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PIK3CG—brain cancer	0.00024	0.00115	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—RELA—brain cancer	0.00024	0.00115	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.00024	0.00114	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—EGFR—brain cancer	0.000239	0.00114	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—ABR—brain cancer	0.000236	0.00112	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DTX2—brain cancer	0.000234	0.00112	CbGpPWpGaD
Captopril—ALB—Hemostasis—MPL—brain cancer	0.000233	0.00111	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TP53—brain cancer	0.000232	0.00111	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000231	0.0011	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTCH2—brain cancer	0.00023	0.0011	CbGpPWpGaD
Captopril—ALB—Hemostasis—S100A10—brain cancer	0.000223	0.00107	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HES5—brain cancer	0.000222	0.00106	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HES1—brain cancer	0.000221	0.00105	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STRADA—brain cancer	0.000216	0.00103	CbGpPWpGaD
Captopril—MMP2—Axon guidance—VEGFA—brain cancer	0.000209	0.000995	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000204	0.000974	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.0002	0.000954	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—RELA—brain cancer	0.000196	0.000933	CbGpPWpGaD
Captopril—F2—Hemostasis—VAV1—brain cancer	0.000195	0.000929	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—RELA—brain cancer	0.000194	0.000928	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000194	0.000924	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	0.000193	0.000922	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—ERBB2—brain cancer	0.000193	0.000922	CbGpPWpGaD
Captopril—MMP2—Axon guidance—EGFR—brain cancer	0.000188	0.000895	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ABR—brain cancer	0.00018	0.00086	CbGpPWpGaD
Captopril—MMP9—Axon guidance—ERBB2—brain cancer	0.000178	0.000847	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTCH2—brain cancer	0.000177	0.000846	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	0.000177	0.000844	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL2—brain cancer	0.000176	0.00084	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GLI2—brain cancer	0.000174	0.00083	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CDK4—brain cancer	0.000173	0.000827	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HES5—brain cancer	0.000172	0.000819	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000172	0.000819	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000169	0.000808	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CTNNB1—brain cancer	0.000169	0.000806	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—IL2—brain cancer	0.000169	0.000805	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000168	0.000804	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STRADA—brain cancer	0.000167	0.000795	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—TRPC6—brain cancer	0.000164	0.000783	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GLI1—brain cancer	0.000164	0.000781	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000163	0.00078	CbGpPWpGaD
Captopril—ALB—Hemostasis—BSG—brain cancer	0.000157	0.00075	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—RELA—brain cancer	0.000155	0.000741	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SUFU—brain cancer	0.000155	0.00074	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—SHH—brain cancer	0.000155	0.000738	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000153	0.00073	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.00015	0.000715	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GFAP—brain cancer	0.00015	0.000714	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TRPC6—brain cancer	0.000149	0.000711	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—VEGFA—brain cancer	0.000149	0.00071	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—STAT3—brain cancer	0.000147	0.000703	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—SMO—brain cancer	0.000147	0.000699	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PTCH1—brain cancer	0.000147	0.000699	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—VEGFA—brain cancer	0.000143	0.000684	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HEY1—brain cancer	0.000142	0.000677	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ABR—brain cancer	0.000139	0.000664	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—DLL1—brain cancer	0.000139	0.000664	CbGpPWpGaD
Captopril—MMP9—Axon guidance—VEGFA—brain cancer	0.000137	0.000653	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GLI2—brain cancer	0.000134	0.000641	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000134	0.00064	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EGFR—brain cancer	0.000134	0.000639	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL2—brain cancer	0.000134	0.000637	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000132	0.00063	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000132	0.000628	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000131	0.000626	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CTNNB1—brain cancer	0.00013	0.000622	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.00013	0.00062	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—VEGFA—brain cancer	0.000128	0.000612	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—RELA—brain cancer	0.000128	0.000608	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—ERBB2—brain cancer	0.000127	0.000605	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GLI1—brain cancer	0.000126	0.000603	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CG—brain cancer	0.000124	0.00059	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000123	0.000588	CbGpPWpGaD
Captopril—MMP9—Axon guidance—EGFR—brain cancer	0.000123	0.000587	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—VAV1—brain cancer	0.000123	0.000587	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	0.000122	0.000583	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000121	0.000577	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SUFU—brain cancer	0.00012	0.000572	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SHH—brain cancer	0.000118	0.000565	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CTNNB1—brain cancer	0.000117	0.00056	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GFAP—brain cancer	0.000116	0.000551	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000115	0.000549	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TRPC6—brain cancer	0.000114	0.000544	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—VEGFA—brain cancer	0.000114	0.000542	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—brain cancer	0.000113	0.000539	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTCH1—brain cancer	0.000112	0.000535	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SMO—brain cancer	0.000112	0.000535	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—VAV1—brain cancer	0.000112	0.000533	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CTNNB1—brain cancer	0.000111	0.000529	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HEY1—brain cancer	0.00011	0.000523	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DLL1—brain cancer	0.000107	0.000513	CbGpPWpGaD
Captopril—ALB—Hemostasis—TRPC6—brain cancer	0.000103	0.000492	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	9.95e-05	0.000475	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VEGFA—brain cancer	9.76e-05	0.000466	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—STAT3—brain cancer	9.66e-05	0.000461	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	9.52e-05	0.000454	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	9.37e-05	0.000447	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SHH—brain cancer	9.14e-05	0.000436	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH2—brain cancer	8.97e-05	0.000428	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	8.93e-05	0.000426	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TRPC6—brain cancer	8.81e-05	0.00042	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EGFR—brain cancer	8.78e-05	0.000419	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2—brain cancer	8.7e-05	0.000415	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTCH1—brain cancer	8.66e-05	0.000413	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SMO—brain cancer	8.66e-05	0.000413	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VAV1—brain cancer	8.55e-05	0.000408	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	7.82e-05	0.000373	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CG—brain cancer	7.81e-05	0.000373	CbGpPWpGaD
Captopril—ALB—Hemostasis—VAV1—brain cancer	7.72e-05	0.000369	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP2C9—brain cancer	7.5e-05	0.000358	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—brain cancer	7.39e-05	0.000353	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HES1—brain cancer	7.35e-05	0.000351	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	7.28e-05	0.000347	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CG—brain cancer	7.09e-05	0.000338	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PDGFRA—brain cancer	7e-05	0.000334	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH2—brain cancer	6.92e-05	0.00033	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SPP1—brain cancer	6.8e-05	0.000324	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	6.7e-05	0.000319	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CTNNB1—brain cancer	6.61e-05	0.000315	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VAV1—brain cancer	6.6e-05	0.000315	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP2C9—brain cancer	6.57e-05	0.000314	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	6.43e-05	0.000307	CbGpPWpGaD
Captopril—ALB—Metabolism—BSG—brain cancer	6.38e-05	0.000304	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.37e-05	0.000304	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP2C9—brain cancer	6.19e-05	0.000295	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IRS2—brain cancer	6.15e-05	0.000293	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	5.69e-05	0.000272	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HES1—brain cancer	5.68e-05	0.000271	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.6e-05	0.000267	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BSG—brain cancer	5.59e-05	0.000267	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—brain cancer	5.59e-05	0.000267	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2—brain cancer	5.5e-05	0.000262	CbGpPWpGaD
Captopril—ALB—Metabolism—IDH1—brain cancer	5.48e-05	0.000262	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APC—brain cancer	5.43e-05	0.000259	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CG—brain cancer	5.43e-05	0.000259	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PDGFRA—brain cancer	5.4e-05	0.000258	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BSG—brain cancer	5.27e-05	0.000251	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SPP1—brain cancer	5.25e-05	0.00025	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.16e-05	0.000246	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.04e-05	0.000241	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2—brain cancer	4.99e-05	0.000238	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CG—brain cancer	4.91e-05	0.000234	CbGpPWpGaD
Captopril—ABCB1—Metabolism—IDH1—brain cancer	4.81e-05	0.000229	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IRS2—brain cancer	4.75e-05	0.000226	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—IDH1—brain cancer	4.53e-05	0.000216	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.47e-05	0.000213	CbGpPWpGaD
Captopril—ALB—Metabolism—ENO2—brain cancer	4.34e-05	0.000207	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RELA—brain cancer	4.24e-05	0.000202	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.23e-05	0.000202	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB2—brain cancer	4.21e-05	0.000201	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APC—brain cancer	4.19e-05	0.0002	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CG—brain cancer	4.19e-05	0.0002	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—brain cancer	3.82e-05	0.000182	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—brain cancer	3.82e-05	0.000182	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ENO2—brain cancer	3.8e-05	0.000181	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCND1—brain cancer	3.72e-05	0.000178	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CTNNB1—brain cancer	3.69e-05	0.000176	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ENO2—brain cancer	3.58e-05	0.000171	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—brain cancer	3.45e-05	0.000165	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RELA—brain cancer	3.27e-05	0.000156	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB2—brain cancer	3.25e-05	0.000155	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—brain cancer	3.25e-05	0.000155	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STAT3—brain cancer	3.21e-05	0.000153	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—brain cancer	2.99e-05	0.000142	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—brain cancer	2.95e-05	0.000141	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—brain cancer	2.93e-05	0.00014	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—brain cancer	2.92e-05	0.000139	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCND1—brain cancer	2.87e-05	0.000137	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CTNNB1—brain cancer	2.85e-05	0.000136	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—brain cancer	2.51e-05	0.00012	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STAT3—brain cancer	2.48e-05	0.000118	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—brain cancer	2.45e-05	0.000117	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—brain cancer	2.31e-05	0.00011	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—brain cancer	2.26e-05	0.000108	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—brain cancer	2.22e-05	0.000106	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CG—brain cancer	1.99e-05	9.49e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—brain cancer	1.89e-05	9.04e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CG—brain cancer	1.74e-05	8.31e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CG—brain cancer	1.64e-05	7.83e-05	CbGpPWpGaD
